Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 692 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

PhaseBio initiates Phase 2b trial of Glymera

The randomised placebo and active comparator controlled Phase 2b trial, targeted to complete by third quarter 2013, will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c